Regenerative Medicine Clinical-Trial Glossary: jRCT, Phase I/II, Eligibility, Endpoints, and Conditional Approval
A plain-language glossary for reading Japanese regenerative-medicine trials: jRCT, recruitment status, Phase I/II, eligibility and exclusion criteria, primary endpoints, adverse events, and conditional, time-limited approval.
